Skip to main content
Log in

Plerixafor plus G-CSF permits more to mobilise but at a cost

  • Clinical study
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

REFERENCE

  1. Delgado E, LeMaistre CF, Bachier C, Smith B, López-González G, Hougham M, Kaleel S, Shaughnessy P.Cost analysis of mobilization and autologous transplantation in patients who received AMD 3100 after failing standard mobilization. 50th Annual Meeting and Exposition of the American Society of Hematology: abstr. 2151, 7 Dec 2008. Available from: URL: http://www.hematology.org

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

Plerixafor plus G-CSF permits more to mobilise but at a cost. Pharmacoecon. Outcomes News 569, 8 (2009). https://doi.org/10.2165/00151234-200905690-00018

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00151234-200905690-00018

Keywords

Navigation